INSIDERFilingvia Quantisnow
Alimera Sciences Inc. logo

Alimera Sciences (ALIM) executive Eiswirth received 500 shares

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Richard S Eiswirth Jr (executive at Alimera Sciences Inc., ALIM) reported that they received 500 shares on Apr 29, 2022. After these transactions the filing shows 136,018 shares held directly.

Reporting person
Eiswirth Richard S Jr
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Apr 29, 2022Grant or award (A)Common Stock1+500$3.76$1,879136,018 direct

Holdings before and after

  • Common Stock: 135,518 to 136,018 direct

Footnotes from the filing

  1. 1. These shares were acquired under the Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d).

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Eiswirth report in this ALIM Form 4?

Richard S Eiswirth Jr (executive at Alimera Sciences Inc., ALIM) reported that they received 500 shares on Apr 29, 2022. After these transactions the filing shows 136,018 shares held directly.

How many ALIM shares does Eiswirth hold after this filing?

The filing shows 136,018 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for ALIM

Earlier insider filings at ALIM

Quantisnow market dataNASDAQ
Alimera Sciences Inc. logo
ALIM
Alimera Sciences Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2010
Get push alerts for ALIM

Follow ALIM and get a push notification the moment its next story breaks.

Full ALIM profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALIM (Alimera Sciences Inc.) and more on Quantisnow.